SANTA FE, N.M., May 6, 2014 /PRNewswire/ -- Sigma Labs, Inc. (OTCBB: SGLB), a developer of advanced, in-process, non-destructive quality inspection systems for metal-based additive manufacturing or 3D printing and other advanced manufacturing technologies, today announced it has signed a Trial Evaluation Agreement with Honeywell International, Inc. (NYSE: HON). The agreement sets forth the parties' intent to use Honeywell's Advanced Manufacturing Engineering Center as a beta test site for its latest PrintRite3D ® DEFORM™ software module for metal-based additive manufacturing.
Mark Cola, President and Chief Executive Officer of Sigma Labs, stated that, "We believe that the signing of this Honeywell agreement, along with previous agreements with major North American Aerospace customers, are significant steps in achieving our 2014 development goals. Further, we believe that following, and as a result of, beta testing at Honeywell over the next several months, a product launch for our PrintRite3D ® DEFORM™ software will be accelerated. Lastly, we believe that our complete suite of PrintRite3D ® software for metal additive manufacturing would enable OEMs like Honeywell to more quickly achieve process certification with enhanced process reliability."
About Sigma Labs, Inc. Sigma Labs, Inc., through its wholly-owned subsidiary B6 Sigma, Inc., develops and engineers advanced, in-process, non-destructive quality inspection systems for commercial firms worldwide seeking productive solutions for metal-based additive manufacturing or 3D printing and other advanced manufacturing technologies. For more information please visit us at www.sigmalabsinc.com.
Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 . Forward-looking statements often contain words such as "expects," "anticipates," "intends," "believes" or "will." Our forward-looking statements are subject to a number of risks, uncertainties and assumptions that could adversely affect us, including the risks set forth in our most recent annual report on Form 10-K. The forward-looking statements in this press release are made only as of the date of this press release. We undertake no obligation to update our forward-looking statements, whether as a result of new information, future events or otherwise.SOURCE Sigma Labs, Inc.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts